S&P 500   3,328.88 (+0.24%)
DOW   29,235.44 (+0.13%)
QQQ   224.56 (+0.57%)
AAPL   319.77 (+1.01%)
FB   222.17 (+0.33%)
GOOGL   1,489.65 (+0.50%)
AMZN   1,891.78 (-0.01%)
BABA   223.09 (+0.37%)
MU   59.18 (+0.36%)
GE   11.43 (-1.97%)
TSLA   568.99 (+3.98%)
AMD   51.35 (+0.59%)
T   39.09 (+1.48%)
F   9.20 (-0.22%)
NFLX   329.33 (-2.60%)
PRI   126.82 (+0.32%)
BAC   34.40 (+0.41%)
DIS   144.49 (+0.65%)
GILD   63.39 (+1.20%)
S&P 500   3,328.88 (+0.24%)
DOW   29,235.44 (+0.13%)
QQQ   224.56 (+0.57%)
AAPL   319.77 (+1.01%)
FB   222.17 (+0.33%)
GOOGL   1,489.65 (+0.50%)
AMZN   1,891.78 (-0.01%)
BABA   223.09 (+0.37%)
MU   59.18 (+0.36%)
GE   11.43 (-1.97%)
TSLA   568.99 (+3.98%)
AMD   51.35 (+0.59%)
T   39.09 (+1.48%)
F   9.20 (-0.22%)
NFLX   329.33 (-2.60%)
PRI   126.82 (+0.32%)
BAC   34.40 (+0.41%)
DIS   144.49 (+0.65%)
GILD   63.39 (+1.20%)
S&P 500   3,328.88 (+0.24%)
DOW   29,235.44 (+0.13%)
QQQ   224.56 (+0.57%)
AAPL   319.77 (+1.01%)
FB   222.17 (+0.33%)
GOOGL   1,489.65 (+0.50%)
AMZN   1,891.78 (-0.01%)
BABA   223.09 (+0.37%)
MU   59.18 (+0.36%)
GE   11.43 (-1.97%)
TSLA   568.99 (+3.98%)
AMD   51.35 (+0.59%)
T   39.09 (+1.48%)
F   9.20 (-0.22%)
NFLX   329.33 (-2.60%)
PRI   126.82 (+0.32%)
BAC   34.40 (+0.41%)
DIS   144.49 (+0.65%)
GILD   63.39 (+1.20%)
S&P 500   3,328.88 (+0.24%)
DOW   29,235.44 (+0.13%)
QQQ   224.56 (+0.57%)
AAPL   319.77 (+1.01%)
FB   222.17 (+0.33%)
GOOGL   1,489.65 (+0.50%)
AMZN   1,891.78 (-0.01%)
BABA   223.09 (+0.37%)
MU   59.18 (+0.36%)
GE   11.43 (-1.97%)
TSLA   568.99 (+3.98%)
AMD   51.35 (+0.59%)
T   39.09 (+1.48%)
F   9.20 (-0.22%)
NFLX   329.33 (-2.60%)
PRI   126.82 (+0.32%)
BAC   34.40 (+0.41%)
DIS   144.49 (+0.65%)
GILD   63.39 (+1.20%)
Log in
(Ad)
Its partners include AT&T, Verizon, Sprint and T-Mobile. It owns more than 200 patents. And analysts say it has "home-run potential." Yet this 5G superstock trades for only $5 a share.

NASDAQ:ATEC - Alphatec Stock Price, Forecast & News

$6.85
+0.01 (+0.15 %)
(As of 01/22/2020 02:54 PM ET)
Today's Range
$6.80
Now: $6.85
$7.69
50-Day Range
$6.47
MA: $6.97
$7.65
52-Week Range
$1.18
Now: $6.85
$7.93
Volume55,270 shs
Average Volume382,938 shs
Market Capitalization$420.32 million
P/E RatioN/A
Dividend YieldN/A
Beta1.56
Alphatec Holdings, Inc, a medical technology company, focuses on the design, development, and promotion of products for the surgical treatment of spine disorders. Its product portfolio and pipeline address the cervical, thoracolumbar, and intervertebral regions of the spine; and cover various spinal disorders and surgical procedures. The company offers MIS products consisting of Battalion Lateral Spacer System and Squadron Lateral Retractor, Illico Minimally Invasive Surgery System, and BridgePoint Spinous Process Fixation System; and fixation products, such as Arsenal Screw System and Zodiac Spinal Fixation Systems. Read More…

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:ATEC
CUSIP02081G10
Phone760-431-9286

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$91.69 million
Book Value$0.41 per share

Profitability

Net Income$-28,980,000.00

Miscellaneous

Employees195
Market Cap$420.32 million
Next Earnings Date3/5/2020 (Estimated)
OptionableNot Optionable

Receive ATEC News and Ratings via Email

Sign-up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.


(Ad)

A U.S. congressional committee passed important legislation that enables each state to set its own policies around cannabis… This bill also allows states to expunge federal marijuana convictions and arrests. This will likely lead to federal legalization sooner than expected. Get in early and you just might be the next 'Marijuana Millionaire'...

Alphatec (NASDAQ:ATEC) Frequently Asked Questions

What is Alphatec's stock symbol?

Alphatec trades on the NASDAQ under the ticker symbol "ATEC."

How were Alphatec's earnings last quarter?

Alphatec Holdings Inc (NASDAQ:ATEC) released its quarterly earnings results on Wednesday, October, 30th. The medical technology company reported ($0.26) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.23) by $0.03. The medical technology company earned $29.20 million during the quarter, compared to analyst estimates of $26.85 million. Alphatec had a negative net margin of 47.55% and a negative return on equity of 151.54%. View Alphatec's Earnings History.

When is Alphatec's next earnings date?

Alphatec is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for Alphatec.

What guidance has Alphatec issued on next quarter's earnings?

Alphatec updated its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $32-32.4 million, compared to the consensus revenue estimate of $30.03 million.

What price target have analysts set for ATEC?

4 analysts have issued 12 month price objectives for Alphatec's shares. Their forecasts range from $6.00 to $15.00. On average, they expect Alphatec's share price to reach $9.25 in the next year. This suggests a possible upside of 35.0% from the stock's current price. View Analyst Price Targets for Alphatec.

What is the consensus analysts' recommendation for Alphatec?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alphatec in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Alphatec.

Has Alphatec been receiving favorable news coverage?

News stories about ATEC stock have trended negative this week, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Alphatec earned a media sentiment score of -2.3 on InfoTrie's scale. They also assigned news stories about the medical technology company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Alphatec.

Are investors shorting Alphatec?

Alphatec saw a increase in short interest in the month of December. As of December 13th, there was short interest totalling 3,320,000 shares, an increase of 15.3% from the November 28th total of 2,880,000 shares. Based on an average trading volume of 340,300 shares, the days-to-cover ratio is presently 9.8 days. Approximately 8.0% of the company's shares are sold short. View Alphatec's Current Options Chain.

Who are some of Alphatec's key competitors?

What other stocks do shareholders of Alphatec own?

Who are Alphatec's key executives?

Alphatec's management team includes the folowing people:
  • Mr. Patrick S. Miles, Exec. Chairman & CEO (Age 53)
  • Mr. Craig E. Hunsaker, Exec. VP of People & Culture, Corp. Sec. and Gen. Counsel (Age 55)
  • Mr. Terry M. Rich, Consultant (Age 51)
  • Mr. Jeffrey P. Rydin, Director (Age 52)
  • Mr. Jeffrey G. Black, Exec. VP & CFO (Age 50)

Who are Alphatec's major shareholders?

Alphatec's stock is owned by a number of of institutional and retail investors. Top institutional investors include Jackson Financial Management (0.41%) and Mesirow Financial Investment Management Inc. (0.11%). Company insiders that own Alphatec stock include Craig E Hunsaker, Evan Bakst, Jeffrey G Black, Jeffrey P Rydin and Kelli Mari Howell. View Institutional Ownership Trends for Alphatec.

Which institutional investors are buying Alphatec stock?

ATEC stock was bought by a variety of institutional investors in the last quarter, including Mesirow Financial Investment Management Inc. and Jackson Financial Management. Company insiders that have bought Alphatec stock in the last two years include Evan Bakst and Kelli Mari Howell. View Insider Buying and Selling for Alphatec.

How do I buy shares of Alphatec?

Shares of ATEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Alphatec's stock price today?

One share of ATEC stock can currently be purchased for approximately $6.85.

How big of a company is Alphatec?

Alphatec has a market capitalization of $420.32 million and generates $91.69 million in revenue each year. The medical technology company earns $-28,980,000.00 in net income (profit) each year or ($0.58) on an earnings per share basis. Alphatec employs 195 workers across the globe.View Additional Information About Alphatec.

What is Alphatec's official website?

The official website for Alphatec is http://www.atecspine.com/.

How can I contact Alphatec?

Alphatec's mailing address is 5818 EL CAMINO REAL, CARLSBAD CA, 92008. The medical technology company can be reached via phone at 760-431-9286 or via email at [email protected]


MarketBeat Community Rating for Alphatec (NASDAQ ATEC)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  246 (Vote Outperform)
Underperform Votes:  358 (Vote Underperform)
Total Votes:  604
MarketBeat's community ratings are surveys of what our community members think about Alphatec and other stocks. Vote "Outperform" if you believe ATEC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ATEC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/22/2020 by MarketBeat.com Staff

Featured Article: Profit Margin

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel